Persistent Immunogenicity of the mRNA COVID-19 Vaccine in Patients Vaccinated Before Kidney Transplant

Transplantation. 2021 Oct 1;105(10):e133-e134. doi: 10.1097/TP.0000000000003872.

Authors

Stephanie G Yi^{1

2}, Todd Eagar³, Linda Moore¹, Howard J Huang^{2

4}, Hassan Ibrahim^{2

5}, Mark J Hobeika^{1

2}, Robert McMillan^{1

2}, Hemangshu Podder^{1

2}, R Mark Ghobrial^{1

2}, A Osama Gaber^{1

2}, Richard J Knight^{1

2}

Affiliations

¹ Department of Surgery, Houston Methodist Hospital, Houston, TX.
² J.C. Walter Jr. Center for Transplantation, Houston Methodist Hospital, Houston, TX.
³ Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX.
⁴ Division of Pulmonology, Department of Internal Medicine, Houston Methodist Hospital, Houston, TX.
⁵ Division of Nephrology, Department of Internal Medicine, Houston Methodist Hospital, Houston, TX.

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Viral / blood*
COVID-19 / prevention & control*
COVID-19 Vaccines / immunology*
Humans
Kidney Transplantation*
Middle Aged
SARS-CoV-2 / immunology*
Vaccination
Vaccines, Synthetic / immunology*
mRNA Vaccines

Substances

Antibodies, Viral
COVID-19 Vaccines
Vaccines, Synthetic